니오지노믹스 (NEO) 주가

니오지노믹스(NEO)는 NAS에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $19.91 (+0.10%), 시가총액 $1.09B.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging…

핵심 지표

• 현재가: $19.91 (+0.10%)
• 시가총액: $1.09B
• 섹터: Healthcare
• 산업: Diagnostics & Research
• 거래소: NAS

니오지노믹스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

니오지노믹스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 매수 (4.0 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 1.27
• 순이익률: -14.85%
• 영업이익률: -6.56%

자주 묻는 질문